Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
G1 (Tikun Olam)
- Development stage
- Unknown
- Lead developer
- Tikun Olam
- Modality
- Small Molecules
- Administration
- Oral, Sublingual
01
Overview
G1 is a proprietary cannabis-based formulation developed by Tikun Olam, specifically designed for digestive support and the management of gastrointestinal disorders. The product is part of Tikun Olam's wellness line and is formulated to alleviate symptoms associated with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, as well as irritable bowel syndrome (IBS). It typically contains a specific ratio of phytocannabinoids, such as cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), which interact with the endocannabinoid system to reduce intestinal inflammation, modulate gut motility, and provide analgesic effects. Tikun Olam's development of G1 is supported by clinical observations and research conducted on their specific cannabis strains in Israel, which have demonstrated efficacy in improving quality of life and reducing disease activity in patients with chronic digestive conditions.
- Brand names
- G1G-1G 1Tikun Olam Digestive Support
- Other names
- Tikun Olam G1
02
Targets
CNR1 (Cannabinoid receptor 1)FAAHHTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))
Beyond the preview
Go deeper on G1 (Tikun Olam).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on G1 (Tikun Olam).